Enveric Biosciences Inc Stock

$1.73

0.52% today

Nasdaq, Feb 05, 04:20 pm CET

ISIN

US29405E1091

Symbol

ENVB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Enveric Biosciences Inc Stock price

$1.74

-3,898.26 99.96% 5Y

Nasdaq, Closing price Tue, Feb 04 2025

-0.07 3.87%

ISIN

US29405E1091

Symbol

ENVB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$1.21m
Enterprise Value	$-1.90m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	0.23
P/B ratio (TTM) P/B ratio	0.26
Revenue (TTM) Revenue	$0.00
EBIT (operating result TTM) EBIT	$-8.84m
Free Cash Flow (TTM) Free Cash Flow	$-8.17m
Cash position	$3.11m
EPS (TTM) EPS	$-38.46
P/E forward	negative
Short interest	3.73%

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Get Started for Free Today

Enveric Biosciences Inc Stock Analysis

Unlock Scores for Free

??

1 Analyst has issued a forecast Enveric Biosciences Inc:

1x Buy

100%

More details on Analyst Estimates Including Price Targets

1 Analyst has issued a forecast Enveric Biosciences Inc:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Enveric Biosciences Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	- -	- 100%
- Direct Costs	0.34 0.34	17% 17% -
Gross Profit	-0.34 -0.34	17% 17% -
- Selling and Administrative Expenses	5.06 5.06	51% 51% -
- Research and Development Expense	3.11 3.11	60% 60% -
EBITDA	-8.50 -8.50	54% 54% -
- Depreciation and Amortization	0.34 0.34	17% 17% -
EBIT (Operating Income) EBIT	-8.84 -8.84	53% 53% -
Net Profit	-9.86 -9.86	56% 56% -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Enveric Biosciences Inc Stock News

Neutral

Business Wire

●

2 days ago

Enveric Biosciences Announces Closing of $5 Million Public Offering

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced the closing of its previously announced public offering of an aggregate of 1,666,666 shares of its co...

Neutral

Business Wire

●

6 days ago

Enveric Biosciences Announces Pricing of $5 Million Public Offering

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today announced the pricing of a public offering of an aggregate of 1,666,666 shares of its common stock (or common s...

Neutral

Business Wire

●

6 days ago

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced that it has received a Notice of Allowance (NOA) from the United States Patent and Trademark Office (USPTO)...

More Enveric Biosciences Inc News

Company Profile

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.

Head office	United States
CEO	Joseph Tucker
Employees	7
Founded	1994
Website	www.enveric.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now